Last updated: 14 February 2022 at 6:00pm EST

Hamza Suria Net Worth




The estimated Net Worth of Hamza Suria is at least $18 million dollars as of 20 December 2021. Mr. Suria owns over 36,645 units of AnaptysBio Inc stock worth over $3,746,722 and over the last 8 years he sold ANAB stock worth over $6,341,649. In addition, he makes $7,875,190 as President, Chief Executive Officer et Director at AnaptysBio Inc.

Mr. Suria ANAB stock SEC Form 4 insiders trading

Hamza has made over 16 trades of the AnaptysBio Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 36,645 units of ANAB stock worth $41,042 on 20 December 2021.

The largest trade he's ever made was selling 65,585 units of AnaptysBio Inc stock on 10 December 2018 worth over $4,687,360. On average, Hamza trades about 15,394 units every 54 days since 2017. As of 20 December 2021 he still owns at least 105,245 units of AnaptysBio Inc stock.

You can see the complete history of Mr. Suria stock trades at the bottom of the page.





Hamza Suria biography

Hamza Suria serves as President, Chief Executive Officer, Director of the Company. From January 2009 to June 2011 Mr. Suria served as Vice President of Corporate Development. Before joining our company in December 2008, Mr. Suria worked at Maxygen, Inc., a biopharmaceutical company, where he was responsible for partnering and alliance management of next-generation protein therapeutics in oncology supportive care, hematology and autoimmunity, including partnerships with healthcare and pharmaceutical companies, such as Roche, Sanofi S.A., Bayer Corporation and Astellas Pharma. Mr. Suria received his M.S. in immunology from the University of Western Ontario, his Executive M.B.A. from the Richard Ivey School of Business of the University of Western Ontario and his B.A. in biochemistry from Kalamazoo College. Our board of directors believes that Mr. Suria’s executive and industry experience, as well as his leadership in the development of our product pipeline across key therapeutic areas, provide him with the qualifications and skills to serve on our board of directors.

What is the salary of Hamza Suria?

As the President, Chief Executive Officer et Director of AnaptysBio Inc, the total compensation of Hamza Suria at AnaptysBio Inc is $7,875,190. There are no executives at AnaptysBio Inc getting paid more.



How old is Hamza Suria?

Hamza Suria is 43, he's been the President, Chief Executive Officer et Director of AnaptysBio Inc since 2011. There are 14 older and no younger executives at AnaptysBio Inc. The oldest executive at AnaptysBio Inc is Hollings Renton, 73, who is the Lead Independent Director.

What's Hamza Suria's mailing address?

Hamza's mailing address filed with the SEC is 10421 Pacific Center Ct, San Diego, CA 92121, USA.

Insiders trading at AnaptysBio Inc

Over the last 8 years, insiders at AnaptysBio Inc have traded over $37,024,151 worth of AnaptysBio Inc stock and bought 5,919,575 units worth $115,520,117 . The most active insiders traders include Holdings A/S Novo, Capital, Llc Eco R1 et James N Topper. On average, AnaptysBio Inc executives and independent directors trade stock every 40 days with the average trade being worth of $4,143,306. The most recent stock trade was executed by Paul F. Lizzul on 14 August 2024, trading 2,000 units of ANAB stock currently worth $37,000.



What does AnaptysBio Inc do?

founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio’s proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c



What does AnaptysBio Inc's logo look like?

AnaptysBio Inc logo

Complete history of Mr. Suria stock trades at AnaptysBio Inc

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
20 Dec 2021 Hamza Suria
Président et PDG
Exercice d'option 36,645 $1.12 $41,042
20 Dec 2021
105,245
4 Nov 2021 Hamza Suria
Président et PDG
Exercice d'option 20,361 $1.12 $22,804
4 Nov 2021
81,938
1 Nov 2021 Hamza Suria
Président et PDG
Exercice d'option 36,646 $1.12 $41,044
1 Nov 2021
104,282
26 Oct 2021 Hamza Suria
Président et PDG
Exercice d'option 15,993 $1.12 $17,912
26 Oct 2021
83,629
17 Sep 2021 Hamza Suria
Président et PDG
Exercice d'option 10,000 $1.12 $11,200
17 Sep 2021
67,636
12 May 2021 Hamza Suria
Président et PDG
Exercice d'option 10,000 $1.12 $11,200
12 May 2021
57,636
10 Mar 2020 Hamza Suria
Président et PDG
Exercice d'option 10,000 $1.12 $11,200
10 Mar 2020
47,636
5 Feb 2020 Hamza Suria
Président et PDG
Exercice d'option 10,000 $1.12 $11,200
5 Feb 2020
37,636
22 Nov 2019 Hamza Suria
Président et PDG
Exercice d'option 10,000 $1.12 $11,200
22 Nov 2019
27,636
10 Jun 2019 Hamza Suria
Président et PDG
Vente 22,428 $73.76 $1,654,289
10 Jun 2019
17,636
17 Apr 2019 Hamza Suria
Président et PDG
Exercice d'option 10,000 $1.12 $11,200
17 Apr 2019
40,064
14 Jan 2019 Hamza Suria
Président et PDG
Exercice d'option 40,000 $1.12 $44,800
14 Jan 2019
70,064
14 Dec 2018 Hamza Suria
Président et PDG
Exercice d'option 41,728 $1.12 $46,735
14 Dec 2018
71,792
10 Dec 2018 Hamza Suria
Président et PDG
Vente 65,585 $71.47 $4,687,360
10 Dec 2018
30,064
9 Jul 2018 Hamza Suria
Président et PDG
Exercice d'option 7,636 $1.73 $13,210
9 Jul 2018
35,062
8 Jun 2018 Hamza Suria
Président et PDG
Exercice d'option 22,428 $2.59 $58,089
8 Jun 2018
27,426


AnaptysBio Inc executives and stock owners

AnaptysBio Inc executives and other stock owners filed with the SEC include: